|
End-of-day quote
Bulgaria S.E.
02/09/2026
|
5-day change | 1st Jan Change | ||
| 2.350 EUR | +2.17% |
|
+8.29% | +64.96% |
| 28/08 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 20/08 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended July 2026 | CI |
| Market Cap | 2.44B 1.47B 1.26B 1.18B 1.08B 2.02B 139B 2.04B 14.01B 5.46B 70.85B 5.51B 5.39B 228B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.98B 1.79B 1.54B 1.45B 1.32B 2.47B 169B 2.49B 17.11B 6.66B 86.56B 6.73B 6.58B 279B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | +2.17% | ||
| 1 week | +8.29% | ||
| Current month | +3.52% | ||
| 1 month | +22.08% | ||
| 3 months | +21.45% | ||
| 6 months | +27.72% | ||
| Current year | +64.96% |
| 1 week | 2.19 |  | 2.35 |
| 1 month | 1.9 | | 2.35 |
| Current year | 1.41 | | 2.35 |
| 1 year | 1.33 | | 2.35 |
| 3 years | 0.94 | | 2.35 |
| 5 years | 0.62 | | 2.35 |
| 10 years | 0.41 | | 2.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/9/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/9/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/9/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.17% | +8.29% | +70.86% | +130.62% | 1.47B | |
| -2.70% | -3.49% | -42.90% | -14.89% | 15.05B | |
| +0.68% | +0.23% | -15.97% | -9.54% | 6.37B | |
| -0.49% | -4.85% | -50.25% | -34.34% | 6.3B | |
| -1.18% | -4.39% | -7.17% | -22.27% | 4.09B | |
| -0.97% | -2.34% | -21.76% | -38.46% | 3.21B | |
| -1.79% | -0.93% | +4.87% | -31.44% | 3.06B | |
| -1.94% | +1.50% | -44.58% | -24.90% | 2.95B | |
| +0.70% | +5.13% | +38.14% | - | 2.47B | |
| -3.76% | -6.95% | -21.34% | -12.97% | 2.41B | |
| Average | -0.93% | -0.59% | -9.01% | -6.47% | 4.74B | |
| Weighted average by Cap. | -1.32% | -1.01% | -23.91% | -16.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.11B 1.04B 949M 1.77B 121B 1.79B 12.27B 4.78B 62.08B 4.83B 4.72B 200B | 2.63B 1.58B 1.36B 1.28B 1.17B 2.18B 149B 2.2B 15.1B 5.88B 76.39B 5.94B 5.81B 246B |
| Net income | 77.85M 46.75M 40.23M 37.75M 34.54M 64.46M 4.42B 64.97M 447M 174M 2.26B 176M 172M 7.27B | 134M 80.19M 69M 64.75M 59.24M 111M 7.58B 111M 766M 298M 3.87B 301M 295M 12.48B |
| Net Debt | 444M 267M 230M 215M 197M 368M 25.22B 371M 2.55B 992M 12.89B 1B 980M 41.51B | 541M 325M 280M 262M 240M 448M 30.73B 452M 3.11B 1.21B 15.7B 1.22B 1.19B 50.58B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | EUR 2.350 | +2.17% | 54,855 |
| 01/09/26 | EUR 2.300 | +1.32% | 846,857 |
| 31/08/26 | EUR 2.270 | +3.65% | 58,848 |
| 28/08/26 | EUR 2.190 | -3.95% | 115,626 |
| 27/08/26 | EUR 2.280 | +5.07% | 119,163 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
